25772-94-5Relevant articles and documents
DIAZEPINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF HEPATITIS B INFECTIONS
-
Page/Page column 135-136, (2018/02/28)
Provided herein are compounds of formula (I) and (V) useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
Potent, orally active corticotropin-releasing factor receptor-1 antagonists containing a tricyclic pyrrolopyridine or pyrazolopyridine core
Dyck, Brian,Grigoriadis, Dimitri E.,Gross, Raymond S.,Guo, Zhiqiang,Haddach, Mustapha,Marinkovic, Dragan,McCarthy, James R.,Moorjani, Manisha,Regan, Collin F.,Saunders, John,Schwaebe, Michael K.,Szabo, Tomas,Williams, John P.,Zhang, Xiaohu,Bozigian, Haig,Chen, Ta Rung
, p. 4100 - 4110 (2007/10/03)
Two new classes of tricyclic-based corticotropin-releasing factor (CRF 1) receptor-1 antagonists were designed by constraining known 1H-pyrrolo[2,3-b]pyridine and 1H-pyrazolo[3,4-b]pyridine ligands. Pyrrole- and pyrazole-based molecules 19g and
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
-
, (2008/06/13)
Method and compositions for treating a patient having a neurological disease or disorder, such as stroke, head trauma, spinal cord injury, spinal cord ischemia, ischemia- or hypoxia-induced nerve cell damage, epilepsy, anxiety, neuropsychiatric or cogniti
